Harrow, Inc. (HROW)
47.12
-1.54
(-3.16%)
USD |
NASDAQ |
Feb 12, 16:00
47.76
+0.64
(+1.36%)
Pre-Market: 09:02
Harrow Cash from Investing (Quarterly) : -0.225M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 14.64M |
| Assertio Holdings, Inc. | -3.812M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.59M |
| Cash from Financing (Quarterly) | 4.964M |
| Free Cash Flow | -20.62M |
| Free Cash Flow Per Share (Quarterly) | 0.4209 |
| Free Cash Flow to Equity (Quarterly) | -4.258M |
| Free Cash Flow to Firm (Quarterly) | 22.40M |
| Free Cash Flow Yield | -1.17% |